Chase AIBulk Dataset ExportPricingFAQsBlog
Display currency
Loading news…

SIRENADE Pharmaceuticals

ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).
München, Bayern, Germany Founded 2002 For Profit

A drug development start-up company that uses an integrated system of molecular tools to develop novel small molecule inhibitors.

SIRENADE Pharmaceuticals on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.

SIRENADE Pharmaceuticals was acquired by Crelux in 2004.
Last Funding
Acquisitions
0
Monthly Visits
Contacts
0

About SIRENADE Pharmaceuticals

Funding & Financials

Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
9

Company Info

Founded
2002
Operating status
Closed
Company type
For Profit
Org types
company
HQ
München, Bayern, Germany
Region
European Union (EU), Europe, Middle East, and Africa (EMEA)
Exit date
Jan 15, 2004
Closed
Jun 14, 2010

Signals & Scores

Heat score
Low
Trend (7d)
0
Trend (30d)
0
Trend (90d)
-0.2

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions
Bulk Dataset Export

Need the data in bulk? Buy the entire dataset.

5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools

Delivered as CSV, JSON or Parquet — at startup-friendly pricing.

See bulk export

Recent News related to SIRENADE Pharmaceuticals

Loading news…

FAQs about SIRENADE Pharmaceuticals

People who checked this page also checked these

Browse the full Acquirezy directory.
SIRENADE Pharmaceuticals — Company Profile